K Venkatakrishnan

Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.

J S Harmatz, D J Greenblatt, D. Greenblatt, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Enhancing value of clinical pharmacodynamics in oncology drug development: An alliance between quantitative pharmacology and translational science

K. Venkatakrishnan, K Venkatakrishnan, J A Ecsedy, 2017, Clinical pharmacology and therapeutics.

Physiologically based and population PK modeling in optimizing drug development: A predict–learn–confirm analysis

K. Venkatakrishnan, K Venkatakrishnan, C Lu, 2015, Clinical pharmacology and therapeutics.

Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug

J Snoeys, S D Hall, L Zhang, 2014, Clinical pharmacology and therapeutics.